Loading...
Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting
Pre-existing antibodies (Abs) to AAV pose a critical challenge for the translation of gene therapies. No effective approach is available to overcome pre-existing Abs. Given the complexity of Ab production, overcoming pre-existing Abs will require broad immune targeting. We generated a mouse model of...
Na minha lista:
| Udgivet i: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363314/ https://ncbi.nlm.nih.gov/pubmed/28345001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.01.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|